Profile
Dr. Ole K.
Hjelstuen is Chief Executive Officer at Inven2 AS.
Ole Kristian Hjelstuen active positions
| Companies | Position | Start |
|---|---|---|
Inven2 AS
 Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | Chief Executive Officer | 2012-03-31 |
Former positions of Ole Kristian Hjelstuen
| Companies | Position | End |
|---|---|---|
| ULTIMOVACS ASA | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ULTIMOVACS ASA | Health Technology |
| Private companies | 1 |
|---|---|
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | Finance |
- Stock Market
- Insiders
- Ole Kristian Hjelstuen
